Providing Over-the-Counter Monograph Submissions in Electronic Format
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 25, 2024
July 25, 2024
772bd042-0dda-4d43-a221-6577f1e823b9
Related Documents
Requests for Reconsideration at the Division Level Under GDUFA
Guidance DocumentOctober 16, 2024Center for Drug Evaluation and Research
Controlled Correspondence Related to Generic Drug Development
Guidance DocumentMarch 18, 2024Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
Guidance DocumentSeptember 26, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox